Morpholino

MO2-rps19

ID
ZDB-MRPHLNO-091103-1
Name
MO2-rps19
Previous Names
  • rps19 splicing MO
Target
Sequence
5' - GCTTCCCCGACCTTTCAAAAGACAA - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-rps19
No data available
Phenotype
Phenotype resulting from MO2-rps19
Phenotype Fish Figures
blood apoptotic process increased process quality, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2014
brain necrotic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
cranial cartilage malformed, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
digestive system position, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
embryo development arrested, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
erythrocyte development disrupted, abnormal WT + MO2-rps19 Fig. 3 from Danilova et al., 2008
erythrocyte differentiation decreased occurrence, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
eye aplastic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
eye decreased size, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
Fig. 2 from Danilova et al., 2008
eye hypoplastic, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
forebrain aplastic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
forebrain decreased size, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
head decreased size, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
Fig. 2 from Danilova et al., 2008
head apoptotic process increased process quality, abnormal WT + MO2-rps19 Fig. 6 with image from Danilova et al., 2014
heart malformed, abnormal WT + MO2-rps19 Fig. 3 from Wilkes et al., 2020
heart primordium position, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
intermediate cell mass of mesoderm erythroblast increased amount, abnormal WT + MO2-rps19 Fig. 3 from Danilova et al., 2008
midbrain hindbrain boundary malformed, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
nucleate erythrocyte decreased amount, abnormal WT + MO2-rps19 Fig. 3 with image from Danilova et al., 2014
Fig. 3 from Danilova et al., 2008
optic primordium decreased size, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
post-vent region kinked, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
trunk curved, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
whole organism apoptotic, abnormal WT + MO2-rps19 Fig. 2 from Danilova et al., 2008
whole organism inha expression decreased amount, abnormal AB + MO2-rps19 Fig. 4 from Danilova et al., 2018
whole organism decreased length, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
whole organism decreased life span, abnormal AB + MO2-rps19 Fig. 6 with image from Danilova et al., 2018
whole organism decreased size, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism cfb expression increased amount, abnormal AB + MO2-rps19 Fig. 5 from Danilova et al., 2018
whole organism ptgs2a expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism cfh expression increased amount, abnormal AB + MO2-rps19 Fig. 5 from Danilova et al., 2018
whole organism il6 expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism tlr3 expression increased amount, abnormal AB + MO2-rps19 Fig. 2 from Danilova et al., 2018
whole organism tlr1 expression increased amount, abnormal AB + MO2-rps19 Fig. 1,  Fig. 2 from Danilova et al., 2018
whole organism tlr9 expression increased amount, abnormal AB + MO2-rps19 Fig. 2 from Danilova et al., 2018
whole organism ifih1 expression increased amount, abnormal AB + MO2-rps19 Fig. 2 from Danilova et al., 2018
whole organism stat1b expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism isg15 expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism fsta expression increased amount, abnormal AB + MO2-rps19 Fig. 4 from Danilova et al., 2018
whole organism tnfa expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism socs3b expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism mmp9 expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism socs3a expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism irf7 expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism irf3 expression increased amount, abnormal AB + MO2-rps19 Fig. 1 from Danilova et al., 2018
whole organism c6.1 expression increased amount, abnormal AB + MO2-rps19 Fig. 5 from Danilova et al., 2018
whole organism fn1b expression increased amount, abnormal AB + MO2-rps19 Fig. 3 from Danilova et al., 2018
whole organism smad7 expression increased amount, abnormal AB + MO2-rps19 Fig. 4 from Danilova et al., 2018
whole organism morphology, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism anterior-posterior axis curved, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism anterior-posterior axis kinked, abnormal WT + MO2-rps19 Fig. 4 from Bibikova et al., 2014
whole organism hemoglobin decreased amount, abnormal WT + MO2-rps19 Fig. 3 from Wilkes et al., 2020
whole organism ribosome decreased amount, abnormal WT + MO2-rps19 Fig. 1 from Danilova et al., 2008
Phenotype of all Fish created by or utilizing MO2-rps19
Phenotype Fish Conditions Figures
whole organism irf7 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
embryo development arrested, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism ptgs2a expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism tlr1 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1,  Fig. 2 from Danilova et al., 2018
whole organism isg15 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism stat1b expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism cfb expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism mmp9 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism decreased length, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism tlr9 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
eye decreased size, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
post-vent region kinked, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism fn1b expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism decreased life span, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism socs3b expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
trunk curved, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
whole organism cfh expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism il6 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
whole organism inha expression decreased amount, abnormal AB + MO2-rps19 standard conditions Fig. 4 from Danilova et al., 2018
whole organism ifih1 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
whole organism socs3a expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism smad7 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 4 from Danilova et al., 2018
whole organism c6.1 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism fsta expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 4 from Danilova et al., 2018
whole organism tlr3 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
whole organism irf3 expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism tnfa expression increased amount, abnormal AB + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2018
head decreased size, abnormal AB + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2018
nucleate erythrocyte decreased amount, abnormal WT + MO2-rps19 standard conditions Fig. 3 with image from Danilova et al., 2014
Fig. 3 from Danilova et al., 2008
whole organism apoptotic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
forebrain aplastic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
eye aplastic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
heart malformed, abnormal WT + MO2-rps19 chemical treatment by environment: metformin Fig. 3 from Wilkes et al., 2020
whole organism decreased size, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
heart primordium position, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
eye decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism anterior-posterior axis kinked, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
eye hypoplastic, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
erythrocyte differentiation decreased occurrence, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
midbrain hindbrain boundary malformed, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
blood apoptotic process increased process quality, abnormal WT + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2014
forebrain decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism morphology, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
brain necrotic, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
digestive system position, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism hemoglobin amount, ameliorated WT + MO2-rps19 chemical treatment by environment: metformin Fig. 3 from Wilkes et al., 2020
erythrocyte development disrupted, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2008
optic primordium decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism anterior-posterior axis curved, abnormal WT + MO2-rps19 control Fig. 4 from Bibikova et al., 2014
head apoptotic process increased process quality, abnormal WT + MO2-rps19 standard conditions Fig. 6 with image from Danilova et al., 2014
whole organism ribosome decreased amount, abnormal WT + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2008
heart malformed, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Wilkes et al., 2020
head decreased size, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
cranial cartilage malformed, abnormal WT + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2008
whole organism hemoglobin decreased amount, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Wilkes et al., 2020
intermediate cell mass of mesoderm erythroblast increased amount, abnormal WT + MO2-rps19 standard conditions Fig. 3 from Danilova et al., 2008
whole organism irf7 expression increased amount, abnormal tp53zdf1/zdf1 + MO2-rps19 standard conditions Fig. 1 from Danilova et al., 2018
whole organism c6.1 expression increased amount, abnormal tp53zdf1/zdf1 + MO2-rps19 standard conditions Fig. 5 from Danilova et al., 2018
whole organism tlr3 expression increased amount, abnormal tp53zdf1/zdf1 + MO2-rps19 standard conditions Fig. 2 from Danilova et al., 2018
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.